Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 361 AL 375

The potential protective effect of tramiprosate (homotaurine) against Alzheimer's disease: a review

Caltagirone C, Ferrannini L, Marchionni N, Nappi G, Scapagnini G, Trabucchi M.

Aging Clin Exp Res. 2012 Dec;24(6):580-7. doi: 10.3275/8585. Epub 2012 Sep 5.

Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain

Raukas M, Rebane R, Mahlapuu R, Jefremov V, Zilmer K, Karelson E, Bogdanovic N, Zilmer M.

Free Radic Res. 2012 Dec;46(12):1490-5. doi: 10.3109/10715762.2012.728286. Epub 2012 Sep 27.

Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales

Clark I, Atwood C, Bowen R, Paz-Filho G, Vissel B.

Pharmacol Rev. 2012 Oct;64(4):1004-26. doi: 10.1124/pr.112.005850. Epub 2012 Sep 10.

Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer's disease

Gu XM, Huang HC, Jiang ZF.

Neurosci Bull. 2012 Oct;28(5):631-40. doi: 10.1007/s12264-012-1270-2. Epub 2012 Sep 12.

The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis

Azizi G, Mirshafiey A.

Immunopharmacol Immunotoxicol. 2012 Dec;34(6):881-95. doi: 10.3109/08923973.2012.705292. Epub 2012 Sep 13.

Meta-analysis on association between the ATP-binding cassette transporter A1 gene (ABCA1) and Alzheimer's disease

Jiang M, Lv L, Wang H, Yang X, Ji H, Zhou F, Zhu W, Cai L, Gu X, Sun J, Dong Q.

Gene. 2012 Dec 1;510(2):147-53. doi: 10.1016/j.gene.2012.09.009. Epub 2012 Sep 13.

The future dominance of combination therapies: implications for today's medical research

de Grey AD.

Rejuvenation Res. 2012 Oct;15(5):443-4. doi: 10.1089/rej.2012.1376.

Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease

Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF.

Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):520-9. doi: 10.1177/1533317512459798. Epub 2012 Sep 17.

Alzheimer's factors in postischemic dementia

Pluta R, Ułamek-Kozioł M, Januszewski S, Sciślewska M, Bogucka-Kocka A, Kocki J.

Rom J Morphol Embryol. 2012;53(3):461-6.

Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter study

Teipel SJ, Wegrzyn M, Meindl T, Frisoni G, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Klöppel S, Hauenstein K, Ewers M; EDSD study group.

J Alzheimers Dis. 2012;31 Suppl 3:S33-47. doi: 10.3233/JAD-2012-112118.

Concise review: Can stem cells be used to treat or model Alzheimer's disease?

Chen WW, Blurton-Jones M.

Stem Cells. 2012 Dec;30(12):2612-8. doi: 10.1002/stem.1240.

Animal models of Alzheimer disease

LaFerla FM, Green KN.

Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a006320. doi: 10.1101/cshperspect.a006320.

Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease

Duron E, Funalot B, Brunel N, Coste J, Quinquis L, Viollet C, Belmin J, Jouanny P, Pasquier F, Treluyer JM, Epelbaum J, le Bouc Y, Hanon O.

J Clin Endocrinol Metab. 2012 Dec;97(12):4673-81. doi: 10.1210/jc.2012-2063. Epub 2012 Sep 26.

Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer`s disease. A meta-analysis

Sadigh-Eteghad S, Talebi M, Farhoudi M.

Neurosciences (Riyadh). 2012 Oct;17(4):321-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias